Global therapeutic respiratory devices market is expected to reach USD 19.2 billion by 2022, according to a new report by Grand View Research Inc. Increasing geriatric population contributing towards growing target disease prevalence levels is a key factor expected to attribute towards market growth.
Rising prevalence of disorders such as COPD and sleep apnea is expected to be a critical growth driver. Prevalence of these disorders is expected to constantly rise over the next six years owing to the growing prevalence of cardiovascular disorders, hypertension, obesity, and other lifestyle induced disorders.
Increasing need of emergency treatment for prolonged illnesses and protracted treatment associated with lung diseases in children as well as adults are expected to drive market growth over the next seven years. The introduction of technology innovations is expected to serve as future growth opportunities.
To request a sample copy or view summary of this report, click the link below:
Further key findings from the study suggest:
Positive airway pressure devices dominated the product segment in 2014, with market size valued at over 4.0 billion. Growing demand for portable PAP devices and high associated efficacy rates are some key factors expected to drive segment growth.
HEPA filtration was the largest technology segment, accounting for over 35.0% of the market share in 2014. High usage of these filters in therapeutic respiratory devices is a major factor contributing towards the segment’s market position.
Furthermore, technological advancements in these filters such as the availability of washable HEPA filters and incorporation of HEPA 4 technology is further likely to boost usage rates.
Regionally, North America dominated the therapeutic respiratory devices market owing to the presence of high diagnosis rates supported by the presence of sophisticated healthcare infrastructure. Increasing government funding, and the availability of well structured reimbursement framework will also contribute towards healthy market growth.
Asia Pacific is expected to witness significant gains, at over 12.0% during the forecast period, driven by the rising incidence of respiratory disorders in the region. Rising healthcare expenditure levels and the presence of high unmet medical need is also a vital growth driver.
Key players operating in the therapeutic respiratory devices market include Smiths Medical, GE Healthcare, CareFusion Corporation, Philips Healthcare and Covidien Plc.
The market is expected to remain highly competitive, which may see extensive R&D investments aimed at technology innovation, as a widely utilized business strategy.
Grand View Research has segmented the global therapeutic respiratory devices market on the basis of products, technology, filters and region:
Product Outlook (Revenue, USD Million, 2012 - 2022)
Piston-based hand-held nebulizers
Fixed oxygen concentrators
Portable oxygen concentrators
Positive airway pressure devices
Continuous positive airway pressure devices
Auto-titrating positive airway pressure devices
Bi-level positive airway pressure devices
Technology Outlook (Revenue, USD Million, 2012 - 2022)
HEPA filter technology
Hollow fiber filtration
Filters Outlook (Revenue, USD Million, 2012 - 2022)
Permanent cleanable filters
Mineral absorption pads
Positive airway pressure device filters
Ultra fine foam inlet filters
Polyester non-woven fiber filters
Acrylic & polypropylene fiber filters
Oxygen concentrators filters
Micro disk filters
Felt intake filters
Hollow membrane filters
Activated carbon filters
Regional Outlook (Revenue, USD Million, 2012 - 2022)
Middle East and Africa (MEA)
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."